Frontiers in nephrology: T cell memory as a barrier to transplant tolerance

Journal of the American Society of Nephrology

Volumn 18, Issue 8, 2007, Pages 2252-2261

  Valujskikh, Anna ^a   Xian, Chang Li ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; BASILIXIMAB; CD134 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; CD8 ANTIGEN; CYCLOSPORIN A; FINGOLIMOD; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 7; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; T LYMPHOCYTE RECEPTOR; TACROLIMUS; THYMOCYTE ANTIBODY;

APOPTOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; EFFECTOR CELL; GRAFT SURVIVAL; HUMAN; KIDNEY GRAFT REJECTION; MEMORY T LYMPHOCYTE; NEPHROLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TRANSPLANTATION TOLERANCE;

EID: 34547637205     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2007020151     Document Type: Review

References (118)

1. Sprent J, Surh CD: T cell memory. Annu Rev Immunol 20: 551-579, 2002
2. Swain SL, Agrewala JN, Brown DM, Jelley-Gibbs DM, Golech S, Huston G, Jones SC, Kamperschroer C, Lee WH, McKinstry KK, Roman E, Strutt T, Weng NP: CD4+ T-cell memory: Generation and multi-faceted roles for CD4+ T cells in protective immunity to influenza. Immunol Rev 211: 8-22, 2006
3. Lefrancois L: Development, trafficking, and function of memory T-cell subsets. Immunol Rev 211: 93-103, 2006
4. Janssen E, Tabeta K, Barnes MJ, Rutschmann S, McBride S, Bahjat KS, Schoenberger SP, Theofilopoulos AN, Beutler B, Hoebe K: Efficient T cell activation via a Toll-interleukin 1 receptor-independent pathway. Immunity 24: 787-799, 2006
5. Borrow P, Tishon A, Lee S, Xu J, Grewal IS, Oldstone MB, Flavell RA: CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. J Exp Med 183: 2129-2142, 1996
6. Hendriks J, Xiao Y, Rossen JW, van der Sluijs KF, Sugamura K, Ishii N, Borst J: During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion. J Immunol 175: 1665-1676, 2005
7. Gramaglia I, Jember A, Pippig SD, Weinberg AD, Killeen N, Croft M: The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion. J Immunol 165: 3043-3050, 2000
8. Suresh M, Whitmire JK, Harrington LE, Larsen CP, Pearson TC, Altman JD, Ahmed R: Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory. J Immunol 167: 5565-5573, 2001
9. Li J, Huston G, Swain SL: IL-7 promotes the transition of CD4 effectors to persistent memory cells. J Exp Med 198: 1807-1815, 2003
10. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R: Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 4: 1191-1198, 2003
11. Dai Z, Konieczny BT, Lakkis FG: The dual role of IL-2 in the generation and maintenance of CD8+ memory T cells. J Immunol 165: 3031-3036, 2000
12. Dooms H, Wolslegel K, Lin P, Abbas AK: Interleukin-2 enhances CD4+ T cell memory by promoting the generation of IL-7R alpha-expressing cells. J Exp Med 204: 547-557, 2007
13. Goldrath AW, Sivakumar PV, Glaccum M, Kennedy MK, Bevan MJ, Benoist C, Mathis D, Butz EA: Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells. J Exp Med 195: 1515-1522, 2002
14. Tan JT, Ernst B, Kieper WC, LeRoy E, Sprent J, Surh CD: Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med 195: 1523-1532, 2002
15. Stockinger B, Bourgeois C, Kassiotis G: CD4+ memory T cells: Functional differentiation and homeostasis. Immunol Rev 211: 39-48, 2006
16. Surh CD, Boyman O, Purton JF, Sprent J: Homeostasis of memory T cells. Immunol Rev 211: 154-163, 2006
17. Robertson JM, MacLeod M, Marsden VS, Kappler JW, Marrack P: Not all CD4+ memory T cells are long lived. Immunol Rev 211: 49-57, 2006
18. Rogers PR, Dubey C, Swain SL: Qualitative changes accompany memory T cell generation: Faster, more effective responses at lower doses of antigen. J Immunol 164: 2338-2346, 2000
19. Tripp RA, Hou S, Doherty PC: Temporal loss of the activated L-selectin-low phenotype for virus-specific CD8+ memory T cells. J Immunol 154: 5870-5875, 1995
20. Zimmerman C, Brduscha-Riem K, Blaser C, Zinkernagel RM, Pircher H: Visualization, characterization, and turnover of CD8+ memory T cells in virus-infected hosts. J Exp Med 183: 1367-1375, 1996
21. Budd RC, Cerottini JC, Horvath C, Bron C, Pedrazzini T, Howe RC, MacDonald HR: Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. J Immunol 138: 3120-3129, 1987
22. Garcia S, DiSanto J, Stockinger B: Following the development of a CD4 T cell response in vivo: From activation to memory formation. Immunity 11: 163-171, 1999
23. Dutton RW, Bradley LM, Swain SL: T cell memory. Annu Rev Immunol 16: 201-223, 1998
24. Seder RA, Ahmed R: Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat Immunol 4: 835-842, 2003
25. Bachmann MF, Gallimore A, Linked: S, Cerundolo V, Lanzavecchia A, Kopf M, Viola A: Developmental regulation of Lck targeting to the CD8 coreceptor controls signaling in naive and memory T cells. J Exp Med 189: 1521-1530, 1999
26. Curtsinger JM, Lins DC, Mescher MF: CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen. J Immunol 160: 3236-3243, 1998
27. Croft M, Bradley LM, Swain SL: Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J Immunol 152: 2675-2685, 1994
28. London CA, Lodge MP, Abbas AK: Functional responses and costimulator dependence of memory CD4+ T cells. J Immunol 164: 265-272, 2000
29. Khayyamian S, Hutloff A, Buchner K, Grafe M, Henn V, Kroczek RA, Mages HW: ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells. Proc Natl Acad Sci U S A 99: 6198-6203, 2002
30. Cho BK, Wang C, Sugawa S, Eisen HN, Chen J: Functional differences between memory and naive CD8 T cells. Proc Natl Acad Sci U S A 96: 2976-2981, 1999
31. Zimmermann C, Prevost-Blondel A, Blaser C, Pircher H: Kinetics of the response of naive and memory CD8 T cells to antigen: Similarities and differences. Eur J Immunol 29: 284-290, 1999
32. Kedl RM, Mescher MF: Qualitative differences between naive and memory T cells make a major contribution to the more rapid and efficient memory CD8+ T cell response. J Immunol 161: 674-683, 1998
33. Veiga-Fernandes H, Walter U, Bourgeois C, McLean A, Rocha B: Response of naive and memory CD8+ T cells to antigen stimulation in vivo. Nat Immunol 1: 47-53, 2000
34. Grayson JM, Harrington LE, Lanier JG, Wherry EJ, Ahmed R: Differential sensitivity of naive and memory CD8+ T cells to apoptosis in vivo. J Immunol 169: 3760-3770, 2002
35. Reinhardt RL, Khoruts A, Merica R, Zell T, Jenkins MK: Visualizing the generation of memory CD4 T cells in the whole body. Nature 410: 101-105, 2001
36. Masopust D, Vezys V, Marzo AL, Lefrancois L: Preferential localization of effector memory cells in nonlymphoid tissue. Science 291: 2413-2417, 2001
37. Moyron-Quiroz JE, Rangel-Moreno J, Hartson L, Kusser K, Tighe MP, Klonowski KD, Lefrancois L, Cauley LS, Harmsen AG, Lund FE, Randall TD: Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs. Immunity 25: 643-654, 2006
38. Sallusto F, Geginat J, Lanzavecchia A: Central memory and effector memory T cell subsets: Function, generation, and maintenance. Annu Rev Immunol 22: 745-763, 2004
39. Obhrai JS, Oberbarnscheidt MH, Hand TW, Diggs L, Chalasani G, Lakkis FG: Effector T cell differentiation and memory T cell maintenance outside secondary lymphoid organs. J Immunol 176: 4051-4058, 2006
40. Chalasani G, Dai Z, Konieczny BT, Baddoura FK, Lakkis FG: Recall and propagation of allospecific memory T cells independent of secondary lymphoid organs. Proc Natl Acad Sci U S A 99: 6175-6180, 2002
41. Unsoeld H, Krautwald S, Voehringer D, Kunzendorf U, Pircher H: Cutting edge: CCR7+ and CCR7- memory T cells do not differ in immediate effector cell function. J Immunol 169: 638-641, 2002
42. Wherry EJ, Teichgraber V, Becker TC, Masopust D, Kaech SM, Antia R, von Andrian UH, Ahmed R: Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 4: 225-234, 2003
43. Ravkov EV, Myrick CM, Altman JD: Immediate early effector functions of virus-specific CD8+CCR7+ memory cells in humans defined by HLA and CC chemokine ligand 19 tetramers. J Immunol 170: 2461-2468, 2003
44. Kassiotis G, Stockinger B: Anatomical heterogeneity of memory CD4+ T cells due to reversible adaptation to the microenvironment. J Immunol 173: 7292-7298, 2004
45. Bingaman AW, Farber DL: Memory T cells in transplantation: Generation, function, and potential role in rejection. Am J Transplant 4: 846-852, 2004
46. Valujskikh A, Lakkis FG: In remembrance of things past: Memory T cells and transplant rejection. Immunol Rev 196: 65-74, 2003
47. Deacock SJ, Lechler RI: Positive correlation of T cell sensitization with frequencies of alloreactive T helper cells in chronic renal failure patients. Transplantation 54: 338-343, 1992
48. Heeger PS, Greenspan NS, Kuhlenschmidt S, Dejelo C, Hricik DE, Schulak JA, TaryLehmann M: Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 163: 2267-2275, 1999
49. Najafian N, Salama A, Fedoseyeva E, Benichou G, Sayegh M: Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: Potential novel assay for prediction of outcomes for renal transplant recipients. J Am Soc Nephrol 13: 252-259, 2002
50. Adams AB, Williams MA, Jones TR, Shirasugi N, Durham MM, Kaech SM, Wherry EJ, Onami T, Lanier JG, Kokko KE, Pearson TC, Ahmed R, Larsen CP: Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 111: 1887-1895, 2003
51. Brehm MA, Markees TG, Daniels KA, Greiner DL, Rossini AA, Welsh RM: Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections. J Immunol 170: 4077-4086, 2003
52. Pantenburg B, Heinzel F, Das L, Heeger PS, Valujskikh A: T cells primed by Leishmania major infection cross-react with alloantigens and alter the course of allograft rejection. J Immunol 169: 3686-3693, 2002
53. Burrows SR, Silins SL, Khanna R, Burrows JM, Rischmueller M, McCluskey J, Moss DJ: Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: Degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity. Eur J Immunol, 27: 1726-1736, 1997
54. Wu Z, Bensinger SJ, Zhang J, Chen C, Yuan X, Huang X, Markmann JF, Kassaee A, Rosengard BR, Hancock WW, Sayegh MH, Turka LA: Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med 10: 87-92, 2004
55. Taylor DK, Neujahr D, Turka LA: Heterologous immunity and homeostatic proliferation as barriers to tolerance. Curr Opin Immunol 16: 558-564, 2004
56. Pober JS, Kluger MS, Schechner JS: Human endothelial cell presentation of antigen and the homing of memory/effector T cells to skin. Ann N Y Acad Sci 941: 12-25, 2001
57. Kobayashi H, Koga S, Novick AC, Toma H, Fairchild RL: T-cell mediated induction of allogeneic endothelial cell chemokine expression. Transplantation 75: 529-536, 2003
58. El-Sawy T, Miura M, Fairchild R: Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis. Am J Pathol 165: 147-157, 2004
59. Chen Y, Heeger PS, Valujskikh A: In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy. J Immunol 172: 5456-5466, 2004
60. Zhang Q, Chen Y, Fairchild RL, Heeger PS, Valujskikh A: Lymphoid sequestration of alloreactive memory CD4 T cells promotes cardiac allograft survival. J Immunol 176: 770-777, 2006
61. Gordon RD, Mathieson BJ, Samelson LE, Boyse EA, Simpson E: The effect of allogeneic presensitization on H-Y graft survival and in vitro cell-mediated responses to H-y antigen. J Exp Med 144: 810-820, 1976
62. Nedelea M, Dima S, Sandru G, Nicolaescu V: A comparative study of allogenic "first set" and "second set" skin rejection in mice. Morphol Embryol 21: 53-57, 1975
63. Azzawi M, Hasleton PS, Geraghty PJ, Yonan N, Krysiak P, El-Gammal A, Deiraniya AK, Hutchinson IV: RANTES chemokine expression is related to acute cardiac cellular rejection and infiltration by CD45RO T-lymphocytes and macrophages. J Heart Lung Transplant 17: 881-887, 1998
64. Ibrahim S, Dawson DV, Sanfilippo F: Predominant infiltration of rejecting human renal allografts with T cells expressing CD8 and CD45RO. Transplantation 59: 724-728, 1995
65. Reinke P, Fietze E, Docke WD, Kern F, Ewert R, Volk HD: Late acute rejection in long-term renal allograft recipients. Diagnostic and predictive value of circulating activated T cells. Transplantation 58: 35-41, 1994
66. van Besouw NM, Zuijderwijk JM, de Kuiper P, Ijzermans JN, Weimar W, van der Mast BJ: The granzyme B and interferon-gamma enzyme-linked immunospot assay as alternatives for cytotoxic T-lymphocyte precursor frequency after renal transplantation. Transplantation 79: 1062-1066, 2005
67. Poggio ED, Clemente M, Hricik DE, Heeger PS: Panel of reactive T cells as a measurement of primed cellular alloimmunity in kidney transplant candidates. J Am Soc Nephrol 17: 564-572, 2006
68. Augustine JJ, Siu DS, Clemente MJ, Schulak JA, Heeger PS, Hricik DE: Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients. Am J Transplant 5: 1971-1975, 2005
69. Pearl JP, Parris J, Hale DA, Hoffmann SC, Bernstein WB, McCoy KL, Swanson SJ, Mannon RB, Roederer M, Kirk AD: Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant 5: 465-474, 2005
70. Goldrath AW, Bogatzki LY, Bevan MJ: Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J Exp Med 192: 557-564, 2000
71. Murali-Krishna K, Ahmed R: Cutting edge: Naive T cells masquerading as memory cells. J Immunol 165: 1733-1737, 2000
72. Sayegh MH, Carpenter CB: Transplantation 50 years later: Progress, challenges, and promises. N Engl J Med 351: 2761-2766, 2004
73. Halloran PF: Immunosuppressive drugs for kidney transplantation. N Engl J Med 351: 2715-2729, 2004
74. Duchini A, Goss JA, Karpen S, Pockros PJ: Vaccinations for adult solid-organ transplant recipients: Current recommendations and protocols. Clin Microbiol Rev 16: 357-364, 2003
75. Gunther M, Neuhaus R, Bauer T, Jilg W, Holtz JA, Bienzle U: Immunization with an adjuvant hepatitis B vaccine in liver transplant recipients: Antibody decline and booster vaccination with conventional vaccine. Liver Transpl 12: 316-319, 2006
76. Enke BU, Bokenkamp A, Offner G, Bartmann P, Brodehl J: Response to diphtheria and tetanus booster vaccination in pediatric renal transplant recipients. Transplantation 64: 237-241, 1997
77. Kumar D, Rotstein C, Miyata G, Arlen D, Humar A: Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients. J Infect Dis 187: 1639-1645, 2003
78. Edvardsson VO, Flynn JT, Deforest A, Kaiser BA, Schulman SL, Bradley A, Palmer J, Polinsky MS, Baluarte HJ: Effective immunization against influenza in pediatric renal transplant recipients. Clin Transplant 10: 556-560, 1996
79. van Lier RA, ten Berge IJ, Gamadia LE: Human CD8(+) T-cell differentiation in response to viruses. Nat Rev Immunol 3: 931-939, 2003
80. Jones DL, Sacks SH, Wong W: Controlling the generation and function of human CD8+ memory T cells in vitro with immunosuppressants. Transplantation 82: 1352-1361, 2006
81. Bemer V, Motta I, Perret R, Truffa-Bachi P: Interleukin-2 down-modulates memory T helper lymphocyte development during antigenic stimulation in vitro. Eur J Immunol 25: 3394-3401, 1995
82. Zhai Y, Meng L, Gao F, Busuttil RW, Kupiec-Weglinski JW: Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: Therapeutic implications for sensitized transplant recipients. J Immunol 169: 4667-4673, 2002
83. Salomon B, Bluestone JA: Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 19: 225-252, 2001
84. Yu X, Carpenter P, Anasetti C: Advances in transplantation tolerance. Lancet 357: 1959-1963, 2001
85. Wekerle T, Kurtz J, Bigenzahn S, Takeuchi Y, Sykes M: Mechanisms of transplant tolerance induction using costimulatory blockade. Curr Opin Immunol 14: 592-600, 2002
86. Larsen CP, Knechtle SJ, Adams A, Pearson T, Kirk AD: A new look at blockade of T-cell costimulation: A therapeutic strategy for long-term maintenance immunosuppression. Am J Transplant 6: 876-883, 2006
87. Kirk AD: Crossing the bridge: Large animal models in translational transplantation research. Immunol Rev 196: 176-196, 2003
88. Kean LS, Gangappa S, Pearson TC, Larsen CP: Transplant tolerance in non-human primates: Progress, current challenges and unmet needs. Am J Transplant 6: 884-893, 2006
89. Valujskikh A, Pantenburg B, Heeger PS: Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am J Transplant 2: 501-509, 2002
90. Turgeon NA, Iwakoshi NN, Phillips NE, Meyers WC, Welsh RM, Greiner DL, Mordes JP, Rossini AA: Viral infection abrogates CD8(+) T-cell deletion induced by costimulation blockade. J Surg Res 93: 63-69, 2000
91. Yamada A, Salama AD, Sayegh MH: The role of novel T cell costimulatory pathways in autoimmunity and transplantation. J Am Soc Nephrol 13: 559-575, 2002
92. Vu MD, Clarkson MR, Yagita H, Turka LA, Sayegh MH, Li XC: Critical, but conditional, role of OX40 in memory T cell-mediated rejection. J Immunol 176: 1394-1401, 2006
93. Yuan X, Salama AD, Dong V, Schmitt I, Najafian N, Chandraker A, Akiba H, Yagita H, Sayegh MH: The role of the CD134-CD134 ligand costimulatory pathway in alloimmune responses in vivo. J Immunol 170: 2949-2955, 2003
94. Yamada A, Salama AD, Sho M, Najafian N, Ito T, Forman JP, Kewalramani R, Sandner S, Harada H, Clarkson MR, Mandelbrot DA, Sharpe AH, Oshima H, Yagita H, Chalasani G, Lakkis FG, Auchincloss H Jr, Sayegh MH: CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo. J Immunol 174: 1357-1364, 2005
95. Murakami M, Sakamoto A, Bender J, Kappler J, Marrack P: CD25+CD4+ T cells contribute to the control of memory CD8+ T cells. Proc Natl Acad Sci U S A 99: 8832-8837, 2002
96. Boyman O, Kovar M, Rubinstein MP, Surh CD, Sprent J: Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311: 1924-1927, 2006
97. Demirci G, Strom TB, Li XC: Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms. J Immunol 171: 3878-3885, 2003
98. el-Sawy T, Fahmy NM, Fairchild RL: Chemokines: Directing leukocyte infiltration into allografts. Curr Opin Immunol 14: 562-568, 2002
99. Anderson BE, McNiff J, Yan J, Doyle H, Mamula M, Shlomchik MJ, Shlomchik WD: Memory CD4+ T cells do not induce graft-versus-host disease. J Clin Invest 112: 101-108, 2003
100. Kreuwel HT, Aung S, Silao C, Sherman LA: Memory CD8+ T cells undergo peripheral tolerance. Immunity 17: 73-81, 2002
101. Beeton C, Barbaria J, Giraud P, Devaux J, Benoliel AM, Gola M, Sabatier JM, Bernard D, Crest M, Beraud E: Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation. J Immunol 166: 936-944, 2001
102. Beeton C, Wulff H, Barbaria J, Clot-Faybesse O, Pennington M, Bernard D, Cahalan MD, Chandy KG, Beraud E: Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc Natl Acad Sci U SA 98: 13942-13947, 2001
103. Dai Z, Li Q, Wang Y, Gao G, Diggs LS, Tellides G, Lakkis FG: CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism. J Clin Invest 113: 310-317, 2004
104. Fehr T, Sykes M: Tolerance induction in clinical transplantation. Transpl Immunol 13: 117-130, 2004
105. Mouzaki A, Rungger D: Properties of transcription factors regulating interleukin-2 gene transcription through the NFAT binding site in untreated or drug-treated naive and memory T-helper cells. Blood 84: 2612-2621, 1994
106. Saunders RN, Metcalfe MS, Nicholson ML: Rapamycin in transplantation: A review of the evidence. Kidney Int 59: 3-16, 2001
107. Eugui EM, Almquist SJ, Muller CD, Allison AC: Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: Role of deoxyguanosine nucleotide depletion. Scand J Immunol 33: 161-173, 1991
108. Aarbakke J, Janka-Schaub G, Elion GB: Thiopurine biology and pharmacology. Trends Pharmacol Sci 18: 3-7, 1997
109. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M: Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270: 286-290, 1995
110. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr: Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270: 283-286, 1995
111. Waldmann TA: Immunotherapy: Past, present and future. Nat Med 9: 269-277, 2003
112. Buhaescu I, Segall L, Goldsmith D, Covic A: New immunosuppressive therapies in renal transplantation: monoclonal antibodies. J Nephrol 18: 529-536, 2005
113. Flynn JM, Byrd JC: Campath-1H monoclonal antibody therapy. Curr Opin Oncol 12: 574-581, 2000
114. Fabian I, Flidel O, Gadish M, Kletter Y, Slavin S, Nagler A: Effects of CAMPATH-1 antibodies on the functional activity of monocytes and polymorphonuclear neutrophils. Exp Hematol 21: 1522-1527, 1993
115. Ginaldi L, De Martinis M, Matutes E, Farahat N, Morilla R, Dyer MJ, Catovsky D: Levels of expression of CD52 in normal and leukemic B and T cells: Correlation with in vivo therapeutic responses to Campath-1H. Leuk Res 22: 185-191, 1998
116. Hale G, Xia MQ, Tighe HP, Dyer MJ, Waldmann H: The CAMPATH-1 antigen (CDw52). Tissue Antigens 35: 118-127, 1990
117. Magliocca JF, Knechtle SJ: The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation. Transpl Int 19: 705-714, 2006
118. Mohty M: Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia April 5, 2007 [epub ahead of print]